Lehrstuhl für Innere Medizin IV


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Chronic Kidney Disease - Diagnosis and Treatment (2021) Galle J, Schmieder R, Weinreich T Journal article Application of win ratio methodology in the Global SYMPLICITY Registry for patients with atrial fibrillation or obstructive sleep apnea (2021) Mahfoud F, Mancia G, Ukena C, Schmieder R, Narkiewicz K, Ruilope L, Schlaich M, et al. Conference contribution Reasons for antihypertensive medication nonadherence influence physician preferences for hypertension management (2021) Schmieder R, Kandzari DE, Wang TD, Lee YH, Haro C, Pathak A Conference contribution Predictors of blood pressure response after renal denervation beyond pretreatment blood pressure (2021) Schmieder R, Delles C, Lauder L, Ott C, Boehm M, Mahfoud F Conference contribution Reduced tissue sodium content is related to improvement of vascular function in patients with chronic heart failure treated with the SGLT2 inhibitor empagliflozin (2021) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Conference contribution Renal nerve ablation in nephritis and beyond (2021) Rodionova K, Ditting T, Veelken R Journal article BKPYV-SPECIFIC T CELLS REDUCE VIRAL LOAD IN A PRIMARY TUBULAR CELL MODEL (2021) Wasielewski E, Lippler S, Knaup K, Gary R, Aigner M, Kremer AL, Pfister F, et al. Conference contribution Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure (2021) Kolwelter J, Bosch A, Jung S, Stabel L, Kannenkeril D, Ott C, Bramlage P, et al. Journal article Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension (2021) Böhm M, Tsioufis K, Kandzari DE, Kario K, Weber MA, Schmieder R, Townsend RR, et al. Journal article Successful treatment of COVID-19 with convalescent plasma in B-cell depleted patients may promote cellular immunity (2021) Kremer A, Kremer A, Willam C, Verhagen J, Achenbach S, Van Der Meiden E, Lang V, et al. Conference contribution